(R)-Tetrahydro-2H-pyran-3-amine hydrochloride

Catalog No.: 
ACRWXT508
CAS No.: 
1315500-31-2
Molecular Formula: 
C5H12ClNO
Molecular Weight: 
137.61
(R)-Tetrahydro-2H-pyran-3-amine hydrochloride structure diagram
Pack SizePurityList PriceYour PriceGlobal StockUS StockQuantity
1g97%$78.00In stockIn stock
5g97%$390.00In stockIn stock
25g97%$1534.00In stockInquiry

Products of AiFChem are all designed for scientific research only. Under no circumstances do we provide products or services for animal or personal utilization.

Product Information

Product Name(R)-Tetrahydro-2H-pyran-3-amine hydrochloride
IUPAC Name(R)-tetrahydro-2H-pyran-3-amine hydrochloride
MDL No.MFCD09056863
Molecular FormulaC5H12ClNO
Molecular Weight137.61
SMILESN[C@H]1COCCC1.[H]Cl
InChI KeyRETPVBQTPDYSBS-NUBCRITNSA-N
Synonym1315500-31-2 | (R)-tetrahydro-2H-pyran-3-amine hydrochloride | (R)-3-Aminotetrahydropyran Hydrochloride | (3r)-oxan-3-amine hydrochloride | (R)-Tetrahydro-pyran-3-ylamine hydrochloride | (3R)-oxan-3-amine;hydrochloride | 2H-Pyran-3-amine, tetrahydro-, hydrochloride (
CAS No.1315500-31-2
PubChem CID56973620

Safety Data

Pictogram
Harmful or irritant
Signal Word
Warning
Hazard Statement(s)
H302-H315-H319-H332-H335
Precautionary Statement(s)
P261-P280-P305+P351+P338

Synthetic Route by SureRoute

1. ACRWXT508 Molecular Building Block Synthetic Route

Source: SureRouteAuthor: aifchem

  1. ACJIPL886 route compound structure diagram
    ACJIPL8861245648-17-2In Stock
  2. Then
  3. ACRWXT508 route product structure diagram
    ACRWXT5081315500-31-2In Stock
Inquiry

2. ACRWXT508 Molecular Building Block Synthetic Route

Source: SureRouteAuthor: aifchem

  1. reactant_1 route compound structure diagram
    --
  2. Then
  3. ACRWXT508 route product structure diagram
    ACRWXT5081315500-31-2In Stock
Inquiry

3. ACRWXT508 Molecular Building Block Synthetic Route

Source: SureRouteAuthor: aifchem

  1. reactant_1 route compound structure diagram
    --
  2. Then
  3. ACRWXT508 route product structure diagram
    ACRWXT5081315500-31-2In Stock
Inquiry

Comments (0)